全文获取类型
收费全文 | 2820篇 |
免费 | 193篇 |
国内免费 | 4篇 |
学科分类
医药卫生 | 3017篇 |
出版年
2021年 | 33篇 |
2020年 | 20篇 |
2019年 | 38篇 |
2018年 | 50篇 |
2017年 | 32篇 |
2016年 | 39篇 |
2015年 | 44篇 |
2014年 | 53篇 |
2013年 | 68篇 |
2012年 | 102篇 |
2011年 | 137篇 |
2010年 | 85篇 |
2009年 | 84篇 |
2008年 | 134篇 |
2007年 | 159篇 |
2006年 | 137篇 |
2005年 | 131篇 |
2004年 | 125篇 |
2003年 | 108篇 |
2002年 | 111篇 |
2001年 | 68篇 |
2000年 | 73篇 |
1999年 | 67篇 |
1998年 | 35篇 |
1997年 | 26篇 |
1996年 | 24篇 |
1995年 | 22篇 |
1994年 | 20篇 |
1992年 | 75篇 |
1991年 | 50篇 |
1990年 | 64篇 |
1989年 | 49篇 |
1988年 | 51篇 |
1987年 | 62篇 |
1986年 | 42篇 |
1985年 | 53篇 |
1984年 | 41篇 |
1983年 | 49篇 |
1982年 | 23篇 |
1980年 | 28篇 |
1979年 | 31篇 |
1978年 | 29篇 |
1977年 | 33篇 |
1976年 | 23篇 |
1975年 | 24篇 |
1974年 | 25篇 |
1973年 | 18篇 |
1972年 | 25篇 |
1971年 | 28篇 |
1970年 | 22篇 |
排序方式: 共有3017条查询结果,搜索用时 0 毫秒
1.
2.
Donald B. Penzien PhD ; Frank Andrasik PhD ; Brian M. Freidenberg PhD ; Timothy T. Houle PhD ; Alvin E. Lake III PhD; Gay L. Lipchik PhD ; Kenneth A. Holroyd PhD ; Richard B. Lipton MD ; Douglas C. McCrory MD ; Justin M. Nash PhD ; Robert A. Nicholson PhD ; Scott W. Powers PhD ABPP ; Jeanetta C. Rains PhD ; David A. Wittrock PhD 《Headache》2005,45(S2):S110-S132
Guidelines for design of clinical trials evaluating behavioral headache treatments were developed to facilitate production of quality research evaluating behavioral therapies for management of primary headache disorders. These guidelines were produced by a Workgroup of headache researchers under auspices of the American Headache Society. The guidelines are complementary to and modeled after guidelines for pharmacological trials published by the International Headache Society, but they address methodologic considerations unique to behavioral and other nonpharmacological treatments. Explicit guidelines for evaluating behavioral headache therapies are needed as the optimal methodology for behavioral (and other nonpharmacologic) trials necessarily differs from the preferred methodology for drug trials. In addition, trials comparing and integrating drug and behavioral therapies present methodological challenges not addressed by guidelines for pharmacologic research. These guidelines address patient selection, trial design for behavioral treatments and for comparisons across multiple treatment modalities (eg, behavioral vs pharmacologic), evaluation of results, and research ethics. Although developed specifically for behavioral therapies, the guidelines may apply to the design of clinical trials evaluating many forms of nonpharmacologic therapies for headache. 相似文献
3.
C Gay Escoda 《Avances en Odontoestomatología》1987,3(4):169-72, 175-9
4.
G. Bradley Schaefer James N. Thompson John B. Bodensteiner James M. McConnell William J. Kimberling Charles T. Gay William D. Dutton David C. Hutchings Stanton B. Gray 《Annals of neurology》1996,39(3):382-385
There are conflicting reports on the relationship between cerebellar vermal lobule hypoplasia and autism. Using quantitative magnetic resonance image analysis, we measured the cerebellar vermis in 125 normal individuals with a broad age range and 102 patients with a variety of neurogenetic abnormalities. We conclude that hypoplasia of cerebellar vermal lobules VI and VII is a nonspecific finding that even occurs in several conditions without autistic behavior. This suggests that it is not a specific neuroanatomical marker for autism, nor is cerebellar dys- genesis likely to be solely responsible for clinical autistic behaviors. 相似文献
5.
6.
7.
8.
9.
10.
Daniel Van Gansbeke Thierry M. Metens Celso Matos Nicole Nicaise France Gay Hubert Raeymaekers Julien Struyven 《Journal of magnetic resonance imaging : JMRI》1997,7(3):482-489
This study was devoted to tumor differentiation in liver MR T1-weighted imaging with superparamagnetic iron oxide (SPIO). Twenty-one patients with 40 liver lesions were studied at 1.5 T. Before and at least 45 minutes after SPIO administration, turbo-field-echo (TFE) T1-weighted, TFE T1 × T2*-weighted (MXT), and fat-suppressed turbo-spin-echo T2-weighted images were acquired. A quantitative analysis was performed blindly. On TFE T1-weighted images, the signal enhancement was ?33% ± 12 for the liver, ?24% ± 2 for adenomas and focal nodular hyperplasia, +60% ± 33 for the hemangiomas; metastases and cyst enhancement were not significant. After SPIO on TFE T1-weighted images, the hemangioma-to-liver signal ratio (149% ± 18) was definitely higher than the mean metastasis-to-liver signal ratio (90% ± 16). This T1-related differentiation ability lacked dramatically on TFE MXT images and, in one case, was reduced on post-SPIO TFE T1-weighted images by a long imaging delay after SPIO administration (2 hours). 相似文献